• Wondering if CME Group at around US$296 per share still offers value, or if most of the opportunity has already been priced in.
• The stock has been relatively steady in the short term, with a 0.9% decline over 7 days and a 5.5% decline over 30 days, while returns sit at 9.8% year to date and 17.2% over the last year, and 77.1% over both 3 and 5 years.
• Recent attention on CME Group has centered on its role as a key exchange operator, with investors watching how trading activity and product mix shape expectations. Broader sector focus on market infrastructure companies has also kept CME Group on the radar of investors assessing long term exposure to financial markets.
• CME Group scores 2 out of 6 on Simply Wall St's valuation checks, as shown by its valuation score. Next up is how different methods like discounted cash flow and multiples compare, and why a more holistic way of thinking about valuation at the end of this article may matter even more.

CME Group scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: CME Group Excess Returns Analysis

The Excess Returns model looks at how much value a company can create over and above the required return that equity investors expect. It focuses on what the business can earn on its equity base after covering its cost of equity.

For CME Group, the model uses a Book Value of $80.03 per share and a Stable EPS estimate of $13.97 per share, based on weighted future Return on Equity estimates from 5 analysts. The Average Return on Equity is 15.79%, while the Cost of Equity is $6.95 per share. The difference is an Excess Return of $7.02 per share, which is effectively the value created after covering what shareholders require.

The Stable Book Value is put at $88.52 per share, using weighted future Book Value estimates from 3 analysts. Feeding these inputs into the Excess Returns framework produces an estimated intrinsic value of about $246.52 per share. With CME Group trading around $296, the model indicates the stock is about 20.2% overvalued on this basis.

Result: OVERVALUED

Our Excess Returns analysis suggests CME Group may be overvalued by 20.2%. Discover 58 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: CME Group Price vs Earnings

For a profitable business like CME Group, the P/E ratio is a useful way to think about what you are paying for each dollar of earnings. It ties the share price directly to current earnings, which is often how many investors quickly compare established companies.

What counts as a "normal" or "fair" P/E depends on how the market views a company’s growth outlook and risk. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth or higher risk usually go with a lower P/E.

CME Group currently trades on a P/E of 26.7x. This sits below the Capital Markets industry average P/E of 41.6x and below the peer group average of 29.4x. Simply Wall St’s Fair Ratio framework goes a step further by estimating what P/E might be reasonable given CME Group’s earnings profile, industry, profit margins, market cap and risk factors. For CME Group, the Fair Ratio is 15.1x, which is meaningfully below the current 26.7x multiple. This suggests the shares are pricing in more than the Fair Ratio implies.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your CME Group Narrative

Earlier it was mentioned that there is an even better way to think about valuation. Narratives on Simply Wall St give you a clear story behind the numbers by linking your view of CME Group’s future revenue, earnings and margins to a forecast and a fair value. They then compare that fair value with the current price, update it automatically as new news or earnings arrive, and let you see how different investors can reasonably land anywhere between a cautious view closer to US$241 and a more optimistic view near US$362, even though they are all looking at the same company on the Community page used by millions of investors.

Do you think there's more to the story for CME Group? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.